Skip to Content
MilliporeSigma
Get up to 22% off for Pi Day until 3/26.Save Now

44714

(S)-Mevalonic acid lithium salt

≥96.0% (GC)

Synonym(s):

Lithium (S)-3,5-dihydroxy-3-methyl-pentanoate, Lithium (S)-3,5-dihydroxy-3-methyl-valerate, S-MVA-Li

Slide 1 of 1
Sign In to View Organizational & Contract Pricing.

Select a Size

10 MG

$347.00

$347.00

Estimated to ship TODAYDetails

​
Request a Bulk Order

About This Item

Empirical Formula (Hill Notation):
C6H12O4 · xLi+
CAS Number:
32451-23-3
Molecular Weight:
148.16 (free acid basis)
MDL number:
MFCD18968029
UNSPSC Code:
12352106
NACRES:
NA.25
Assay:
≥96.0% (GC)
Quality level:
100

Key Documents

View All Documentation

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

SMILES string

O[C@@](CCO)(CC(=O)O)C

InChI

1S/C6H12O4/c1-6(10,2-3-7)4-5(8)9/h7,10H,2-4H2,1H3,(H,8,9)/t6-/m0/s1

InChI key

KJTLQQUUPVSXIM-LURJTMIESA-N

assay

≥96.0% (GC)

optical activity

[α]/D +25.0±3.0°, c = 0.1 in 1 M HCl

storage temp.

2-8°C

Quality Level

100

Looking for similar products? Visit Product Comparison Guide

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
904697984989517
(S)-Mevalonic acid lithium salt ≥96.0% (GC)

Sigma-Aldrich

44714

(S)-Mevalonic acid lithium salt

(RS)-Mevalonic acid lithium salt ≥96.0% (GC)

Sigma-Aldrich

90469

(RS)-Mevalonic acid lithium salt

(±)-Mevalonic acid 5-phosphate lithium salt hydrate 95% (TLC)

Sigma-Aldrich

79849

(±)-Mevalonic acid 5-phosphate lithium salt hydrate

(S)-3,4-Dihydroxybutyric acid lithium salt hydrate ≥95.0% (GC)

Sigma-Aldrich

89517

(S)-3,4-Dihydroxybutyric acid lithium salt hydrate

assay

≥96.0% (GC)

assay

≥96.0% (GC)

assay

95% (TLC)

assay

≥85% (free acid, qNMR), ≥95.0% (GC)

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

−20°C

optical activity

[α]/D +25.0±3.0°, c = 0.1 in 1 M HCl

optical activity

-

optical activity

-

optical activity

[α]/D -25±5°, 24 hr, c = 0.1 in 0.1 M HCl

Biochem/physiol Actions

Metabolite of the mevalonate pathway, which plays a key role in the biosynthesis of sterols, dolichol, heme and ubiquinone. Of interest for research in the disease areas oncology, autoimmune diseases, artherosclerosis and Alzheimer disease, as well as for inherited deficiencies of mevalonate kinase.

Packaging

Bottomless glass bottle. Contents are inside inserted fused cone.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCB5696
BCBN5844V
BCBJ7994V
BCBG8923

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

R R Kopito et al.
Journal of lipid research, 23(4), 577-583 (1982-05-01)
A circadian rhythm in plasma mevalonate was identified in human subjects. This variation, over a 5-fold range, is paralleled by a rhythm in urinary excretion. No such diurnal change in plasma mevalonate was observed in schedule-fed, light-cycled rats, despite the
R A Larson et al.
Blood, 64(1), 257-262 (1984-07-01)
Mevalonic acid can stimulate leukemic cells from some patients with B cell chronic lymphocytic leukemia (CLL) to enter the cell cycle in vitro and to synthesize DNA. Unlike normal human peripheral blood lymphocytes, which require the presence of granulocytes for
Le-Le Hu et al.
PloS one, 6(12), e29491-e29491 (2012-01-06)
Given a compound, how can we effectively predict its biological function? It is a fundamentally important problem because the information thus obtained may benefit the understanding of many basic biological processes and provide useful clues for drug design. In this
Priti Agarwal et al.
The Journal of investigative dermatology, 135(4), 1080-1088 (2014-12-19)
Vitiligo is a common autoimmune disease of the skin that results in disfiguring white spots. There are no Food and Drug Administration (FDA)-approved treatments, and current treatments are time-consuming, expensive, and of low efficacy. We sought to identify new treatments

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service